Your Source for News about Stem Cells and CRISPR
Latest news from all over the web about stem cell research by category and topics of interest.
Latest News about Stem Cells at Your Fingertips
We aggregate and curate news from all over the web and social media, organizing them by categories and topics of interest, so you could make your own decisions about events, technologies and people connected with stem cell therapies.
From Comprehensive Care to Finding Cures, Fighting Sickle Cell Disease
Some of Stanford Children’s sickle cell care team: Elaine Macasiray, RN, Kimberly Vierhus, RN, Aditi Kamdar, MD, Kirsten Mouradian, FNP (left to right).Blood. There’s A, [...]
SEAS forms center to advance cell, gene and tissue engineering research
A team of UB researchers in chemical, biological and biomedical engineering have joined forces to develop innovative technologies for regenerative medicine and educate future leaders [...]
Off-the-Shelf CAR T-Cell Product CTX100 Promising in Relapsed/Refractory CD19+ B-Cell …
The investigational wholly-owned allogeneic chimeric antigen receptor (CAR) T-cell therapy CTX110 demonstrated dose-dependent efficacy and responses in patients with relapsed/refractory CD19-positive B-cell malignancies, according to [...]
Clinical Catch-Up: October 19-23
It was another busy week for clinical trial updates and news. Here’s a look. COVID-19-Related The U.S. Army Medical Research and Development (USAMRDC) initiated a [...]
Off-the-Shelf CAR T-Cell Product CTX100 Shows Early Activity in Relapsed/Refractory CD19+ B …
The investigational wholly-owned allogeneic chimeric antigen receptor (CAR) T-cell therapy CTX110 demonstrated dose-dependent efficacy and responses in patients with relapsed/refractory CD19-positive B-cell malignancies, according to [...]
Supramolecular nanosubstrate–mediated delivery system enables CRISPR-Cas9 knockin of …
AbstractLeveraging the endogenous homology-directed repair (HDR) pathway, the CRISPR-Cas9 gene-editing system can be applied to knock in a therapeutic gene at a designated site in [...]
Novel Engineered CAR T Cells Show Early Promise in CD19+ B-Cell Malignancies
Chimeric antigen receptor (CAR) T-cell therapy with the novel agent CTX110 showed promising early efficacy and safety as treatment of patients with relapsed or refractory [...]
Despite One Patient Death, CRISPR Therapeutics' Off-the-Shelf CAR-T Shows Promise
Despite promising Phase I data for its CRISPR-based allogeneic CAR-T therapy, CRISPR Therapeutics may have a safety issue to contend with. The company, whose scientific [...]
Gene editing points to relief for sickle cell patients
Last summer, a woman named Victoria Gray was the first to receive a new type of therapy to treat sickle cell disease.Scientists removed some of [...]
Clues to Brain Development and Disease Emerge from 3D Epigenome Study
Research October 14, 2020 ‘Dark Matter’ DNA Linked to Cell-Specific Patterns of Gene Activity By Jeffrey Norris Image shows staining for GPX3, a radial glia [...]
BioSpace Global Roundup, Oct. 15
AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. All jobs have been maintained and [...]
2020, a record year for regenerative medicine and advanced therapies
2020 was an unprecedented year so far for the regenerative medicine and advanced therapies sector. Not only because of the inevitable impact of the COVID-19 [...]
Weekly reads on organoids, COVID, CRISPR, cold chromatin, more
As a researcher, is there ever enough time to get to everything that you want to read especially in newer areas like stem cells, organoids, [...]
UTSW Scientist: 'We Need More Women Thinking Creatively in the Lab and Pushing Science …
[Image: Oleksandr Bushko/istockphoto] It’s rare to have a woman winning a Nobel Prize, much less two women on the same day and three in the [...]
Taking Gene Editing to the Brain, the Immune System, and More
One of the most remarkable recent advances in biomedical research has been the development of highly targeted gene-editing methods such as CRISPR that can add, [...]
Explained: CRISPR Gene Editing, Winner of 2020 Chemistry Nobel Prize
Scientists discovered some bacteria can cut the DNA of invading viruses as a defence mechanism. They realised they could use this to cut human DNA. [...]
The Global Stem Cell Therapy Market Growth To 2023 Will Be Driven By Increasing Prevalence Of …
"Global Stem Cell Therapy Market, Forecast Market Size, 2019 – 2023, $ Billion"The Business Research Company’s Global Stem Cell Therapy Market Report 2020-30: Covid 19 [...]
Nobel win highlights Li Ka-shing role in medical research
HONG KONG -- Li Ka-shing may have dropped out of school at age 12, but that lack of educational achievement did not stop Hong Kong's [...]
Options for treating sickle cell disease expanded last fall
Two new therapy options won Food and Drug Administration approval within 10 days of each other in November 2019, blooms of hope in what has [...]
A small switch with a big impact
Minor changes in immune cells can significantly affect the immune response, scientists of the University of Würzburg have now discovered. Their findings could be relevant [...]
Gladstone researchers awarded $3.2 million to study cellular energy
A team of Gladstone researchers has received a grant of more than $3.2 million from the National Institutes of Health (NIH) to study how cells [...]
Timothy Ray Brown, First Person to Be Cured of HIV, Dies
Timothy Ray Brown, who became the first HIV patient to be cured of the infection, died September 29 of leukemia—the very disease that led to [...]
Parkinson's research at UC Berkeley funded by $14 million grant
Two grants totaling nearly $14 million to be distributed over three years have been awarded to fund research at UC Berkeley on the causes of [...]
Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees
Sept. 29, 2020 15:50 UTC HANGZHOU, China--(BUSINESS WIRE)-- Qihan Biotech, a leader in applying genome editing technology to cell therapies and organ transplantation, today announced [...]